Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thymic function in HIV infection.

Rohan Hazra1, Crystal Mackall

  • 1Pediatric Oncology Branch, National Cancer Institute, Bldg. 10-CRC Rm. 1W-3940, 10 Center Drive, MSC 1104, Bethesda, MD 20892, USA.

Current HIV/AIDS Reports
|August 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dynamic, single-cell monitoring of CAR T cell identity and activation with Raman spectroscopy.

bioRxiv : the preprint server for biology·2026
Same author

Lessons Learned from Community Contact Tracing of Women Disengaged from an Urban Prevention of Mother-to-Child Transmission Program in Uganda.

Maternal and child health journal·2026
Same author

CAR T cells: the missing piece needed to improve outcomes for children with cancer?

Journal for immunotherapy of cancer·2026
Same author

CAR19 therapy drives expansion of clonal hematopoiesis and associated cytopenias.

Research square·2025
Same author

Napsin A-specific T-cell clonotypes are associated with improved clinical outcomes in patients receiving checkpoint immunotherapy for metastatic non-small cell lung cancer.

Journal for immunotherapy of cancer·2025
Same author

CSF1R<sup>+</sup> myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma.

Cancer cell·2025
Same journal

IAS 2025: Why Can't I Breastfeed My Baby When Evidence and Lived Experience Say I Can? A Call for Policy Equity for Mothers Living with HIV.

Current HIV/AIDS reports·2026
Same journal

Cytomegalovirus and HIV Co-Infections During Pregnancy and Early Childhood.

Current HIV/AIDS reports·2026
Same journal

HIV Reservoirs in Brain parenchyma and Cerebrospinal Fluid During Suppressive ART: Same-Same or Very Different?

Current HIV/AIDS reports·2026
Same journal

HIV-1 Tat-driven Glutamate Dysregulation: Implications for Cognitive Impairment in HAND.

Current HIV/AIDS reports·2026
Same journal

Central Nervous System HIV Persistence and Clinical Consequences During Suppressive ART.

Current HIV/AIDS reports·2026
Same journal

Expanding PrEP Access Through Decentralized Delivery Models.

Current HIV/AIDS reports·2026
See all related articles

Human immunodeficiency virus (HIV) depletes CD4+ cells, but effective therapy can restore immune function by promoting thymic regeneration. Certain HIV strains may cause irreversible thymic damage, hindering immune recovery.

Area of Science:

  • Immunology
  • Virology
  • HIV/AIDS Research

Background:

  • Current models explain CD4+ T-cell depletion in HIV infection through direct and indirect viral effects, impairing cell survival and regeneration.
  • While aging and HIV's thymotoxicity reduce thymic function, clinical trials show immune reconstitution in many patients on highly active antiretroviral therapy (HAART).
  • Insufficient immune recovery post-HAART often correlates with a lack of thymopoiesis, indicating thymic dysfunction.

Purpose of the Study:

  • To investigate the causes of thymic failure in HIV-infected individuals.
  • To understand the role of specific HIV strains in thymic damage and immune reconstitution.

Main Methods:

  • Analysis of clinical trial data on immune reconstitution in patients undergoing HAART.

Related Experiment Videos

  • Assessment of thymopoiesis in patients with varying levels of immune recovery.
  • Investigation of the thymotoxicity of different HIV strains, particularly CXCR4-tropic variants.

    • Main Results:

    • A significant proportion of patients achieving viral control with HAART show evidence of thymic-dependent immune reconstitution.
    • Patients with poor immune reconstitution after HAART typically lack signs of thymopoiesis.
    • Certain HIV strains, especially CXCR4-tropic ones, exhibit enhanced thymotoxicity and may lead to irreversible thymic damage.

    Conclusions:

    • Effective HAART can facilitate thymic regeneration and immune recovery in HIV-infected individuals.
    • Thymic function is crucial for immune reconstitution following HIV treatment.
    • Specific HIV strains pose a greater risk for permanent thymic damage, impacting long-term immune competence.